ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,258Medicare Part D Prescriptions Filled, Including Refills

Rank: 120 out of 6969

$741K Total Retail Price of All Prescriptions

Rank: 255 out of 6969

612 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 612 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 14,893 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METFORMIN HCL 842 777 1 7
AMLODIPINE BESYLATE 776 728 2 4
LOVASTATIN 597 547 3 15
LEVOTHYROXINE SODIUM 587 558 4 5
SIMVASTATIN 559 476 5 1
LOSARTAN POTASSIUM 516 469 6 12
OMEPRAZOLE 474 444 7 6
LISINOPRIL 470 401 8 2
TAMSULOSIN HCL 328 320 9 23
DIOVAN HCT 324 293 10 57
HYDROCHLOROTHIAZIDE 296 274 11 8
DIOVAN 291 281 12 26
ATENOLOL 280 270 13 9
GABAPENTIN 247 239 14 17
CARVEDILOL 247 208 14 25
ALENDRONATE SODIUM 238 231 16 14
JANUVIA 233 190 17 41
TRAMADOL HCL-ACETAMINOPHEN 225 209 18 279
ZOLPIDEM TARTRATE 217 208 19 16
CILOSTAZOL 212 212 20 208
RANITIDINE HCL 210 189 21 46
FUROSEMIDE 205 203 22 10
SULINDAC 178 157 23 267
HYDROCODONE-ACETAMINOPHEN 172 164 S3 24 3
PRAVASTATIN SODIUM 164 155 25 19
GLIPIZIDE 156 125 26 21
FENOFIBRATE 148 133 27 63
CLONIDINE HCL 145 144 28 59
LOSARTAN-HYDROCHLOROTHIAZIDE 128 102 29 53
GLYBURIDE 124 120 R 30 54
FINASTERIDE 115 115 31 80
METOPROLOL TARTRATE 113 110 32 13
DOXAZOSIN MESYLATE 112 98 33 74
ATORVASTATIN CALCIUM 110 97 34 11
PROAIR HFA 109 100 35 33
OXYBUTYNIN CHLORIDE 106 94 36 126
DONEPEZIL HCL 98 98 37 32
PANTOPRAZOLE SODIUM 95 65 38 31
GALANTAMINE HBR 94 94 39 275
PAROXETINE HCL 93 91 40 65
PROMETHAZINE HCL 91 87 R 41 203
NATEGLINIDE 85 85 42 228
ACETAMINOPHEN-CODEINE 84 79 S3 43 73
LOVAZA 84 64 43 77
TRICOR 84 83 43 143
ALPRAZOLAM 83 71 46 172
FLUTICASONE PROPIONATE 82 77 47 24
NAMENDA 81 81 48 51
ZETIA 79 78 49 98
TRAMADOL HCL 77 72 50 27
NYSTATIN-TRIAMCINOLONE 76 75 51 278
IBUPROFEN 76 70 51 29
MINOXIDIL 76 76 51 436
MELOXICAM 75 63 54 36
FELODIPINE ER 73 70 55 116
BENAZEPRIL HCL 70 69 56 18
DILTIAZEM 24HR ER 69 69 57 183
VALSARTAN-HYDROCHLOROTHIAZIDE 68 60 58 346
ALLOPURINOL 66 58 59 35
MECLIZINE HCL 65 64 60 100
DILTIAZEM ER 63 63 61 206
AMOXICILLIN 61 57 62 99
CLOPIDOGREL 60 56 63 48
ACTOS 58 48 64 61
SERTRALINE HCL 54 49 65 38
CIPROFLOXACIN HCL 52 50 66 64
FAMOTIDINE 51 37 67 37
LANTUS 50 43 68 50
EXFORGE 50 50 68 190
AMITRIPTYLINE HCL 50 40 R 68 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.